193 related articles for article (PubMed ID: 23160320)
1. A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer.
Somaiah N; Simon NG; Simon GR
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S342-68. PubMed ID: 23160320
[No Abstract] [Full Text] [Related]
2. Molecular targeted agents and biologic therapies for non-small cell lung cancer.
Somaiah N; Simon GR
J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S434-54. PubMed ID: 21102235
[No Abstract] [Full Text] [Related]
3. Molecular targeted agents and biologic therapies for lung cancer.
Somaiah N; Simon GR
J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1758-85. PubMed ID: 22005529
[No Abstract] [Full Text] [Related]
4. A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer.
Simon GR; Somaiah N
Clin Lung Cancer; 2014 Jan; 15(1):21-51. PubMed ID: 24377743
[TBL] [Abstract][Full Text] [Related]
5. Molecularly targeted therapies in locally advanced non-small-cell lung cancer.
Devarakonda S; Morgensztern D; Govindan R
Clin Lung Cancer; 2013 Sep; 14(5):467-72. PubMed ID: 23684057
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol-3-kinase pathway.
Reckamp KL
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S383-4. PubMed ID: 23160326
[No Abstract] [Full Text] [Related]
7. Phosphatidykinosital 3-kinase and mammalian target of rapamycin pathway in non-small-cell lung cancer.
Massarelli E; Papadimitrakopoulou VA
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S379-82. PubMed ID: 23160325
[No Abstract] [Full Text] [Related]
8. Update on HER1-3 in advanced non-small-cell lung cancer.
Horn L; Lovly C
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S369-71. PubMed ID: 23160321
[No Abstract] [Full Text] [Related]
9. Doubling down with inhibitors of Notch and Hedgehog signaling pathways.
Weiss GJ
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S409-10. PubMed ID: 23160337
[No Abstract] [Full Text] [Related]
10. Targeted therapy in lung cancer: lessons learned from past experiences.
Subramanian J; Waqar SN; Govindan R
J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1786-8. PubMed ID: 22005530
[No Abstract] [Full Text] [Related]
11. Summary of the proceedings from the 10th annual meeting of molecularly targeted therapy in non-small cell lung cancer.
Govindan R
J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S433. PubMed ID: 21102234
[No Abstract] [Full Text] [Related]
12. Targeting fibroblast growth factor receptor and discoidin domain receptor 2 in non-small-cell lung cancer.
Riess JW; Neal JW
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S385-6. PubMed ID: 23160327
[No Abstract] [Full Text] [Related]
13. Clinical Trials of PD-1 and PD-L1 inhibitors in NSCLC.
Clin Adv Hematol Oncol; 2014 Jan; 12(1 Suppl 1):14-6. PubMed ID: 24852398
[No Abstract] [Full Text] [Related]
14. Three cheers for targeted therapy in non-small cell lung cancer... When we hit the target!
Codacci-Pisanelli G; Frati L; Mini E
J Chemother; 2011 Aug; 23(4):245-6. PubMed ID: 21803707
[No Abstract] [Full Text] [Related]
15. Targeted lung cancer therapies.
Farmer G
Nat Rev Drug Discov; 2004 Jul; 3(7):547-8. PubMed ID: 15272497
[No Abstract] [Full Text] [Related]
16. New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.
Zarogoulidis P; Yarmus L; Zarogoulidis K
Ther Deliv; 2013 Oct; 4(10):1221-3. PubMed ID: 24116905
[No Abstract] [Full Text] [Related]
17. Developing targeted therapies for lung cancer.
Gandara DR
Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
[No Abstract] [Full Text] [Related]
18. New targets for non-small-cell lung cancer therapy.
Alvarez M; Roman E; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
[TBL] [Abstract][Full Text] [Related]
19. Hsp90 inhibitors.
Pillai RN; Ramalingam SS
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S407-8. PubMed ID: 23160336
[No Abstract] [Full Text] [Related]
20. [The update of emerging targeted therapies of lung cancer].
Shang CC; Zhang L
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):447-449. PubMed ID: 28592047
[No Abstract] [Full Text] [Related]
[Next] [New Search]
